Oestrogen ring vs other regimens
Oestrogen ring may leads to lower endometrial thickness (oestrogen ring vs oestrogen cream) compared with other regimens (low certainty).
- OR 0.36 [0.14, 0.94]2 studies · 273 participantsLow
Oestrogen ring may leads to lower endometrial thickness (oestrogen ring vs oestrogen cream) compared with other regimens (low certainty).
Oestrogen ring showed no clear difference in improvement in symptoms (clinician‐assessed) (oestrogen ring vs… compared with other regimens (low certainty).
Oestrogen ring showed no clear difference in improvement in symptoms (clinician‐assessed) (oestrogen ring vs… compared with other regimens (low certainty).
Oestrogen ring showed no clear difference in adverse events (total adverse events) (oestrogen ring vs oestrogen… compared with other regimens (low certainty).
Oestrogen ring showed no clear difference in adverse events (total adverse events) (oestrogen ring vs placebo) compared with other regimens (moderate certainty).
Oestrogen tablets showed no clear difference in improvement in symptoms (participant‐assessed) (oestrogen tablets vs… compared with other regimens (low certainty).
Oestrogen tablets may leads to higher improvement in symptoms (participant‐assessed) (oestrogen tablets vs… compared with other regimens (low certainty).
GnRH antagonist showed no clear difference in live birth rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
GnRH antagonist probably leads to lower OHSS per woman randomised (any grade) compared with long‐course GnRH agonist (moderate certainty).
GnRH antagonist showed no clear difference in ongoing pregnancy rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
GnRH antagonist showed no clear difference in clinical pregnancy rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
GnRH antagonist showed no clear difference in miscarriage rate per woman randomised compared with long‐course GnRH agonist (moderate certainty).
GnRH antagonist probably leads to higher cycle cancellation due to poor ovarian response compared with long‐course GnRH agonist (moderate certainty).
The review found no eligible studies for this question.
Dietary supplements may leads to higher zataria versus placebo Pain relief compared with placebo (low certainty).
It is very uncertain whether dietary supplements changes zinc sulphate versus placebo Adverse effects compared with placebo (very low certainty).
It is very uncertain whether dietary supplements changes ginger versus placebo Adverse effects compared with placebo (very low certainty).
The review found no eligible studies for this question.